ARWR
Conviction 27HealthcareScan · Thu, Sep 24, 2026Arrowhead Pharmaceuticals, Inc. (ARWR) closed at $66.06 (-1.34%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 31, RS Rating 94, -26.3% from its 52-week high, -2.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Price, News, Quote & Historyca.finance.yahoo.com · Wed, Sep 23, 2026
Congress activity
Disclosed STOCK Act trades in ARWR
Insider activity
SEC Form 4 transactions in ARWR · open-market 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
OLUKOTUN ADEOYE Y Director · Common Stock · 2026-08-18 | Sell | 2K | $174K | 2026-08-18 | 2026-08-20 |
PERRY MICHAEL S Director · Common Stock · 2026-08-18 | Sell | 11.6K | $1.0M | 2026-08-18 | 2026-08-20 |
Cohen Matthew Gregory Director · Common Stock · 2026-06-15 | Grant | 11.88K | — | 2026-06-15 | 2026-06-17 |
Lu Hongbo Director · Common Stock · 2026-05-12 | Sell | 2.97K | $228K | 2026-05-12 | 2026-05-14 |
Hamilton James C Chief Medical Officer · Common Stock · 2026-04-23 | Sell | 10K | $750K | 2026-04-23 | 2026-04-24 |
Apel Daniel Joseph Chief Financial Officer · Common Stock · 2026-04-22 | Sell | 3.21K | $225K | 2026-04-22 | 2026-04-24 |
Apel Daniel Joseph Chief Financial Officer · Common Stock · 2026-04-22 | Sell | 8.73K | $628K | 2026-04-22 | 2026-04-24 |
Apel Daniel Joseph Chief Financial Officer · Common Stock · 2026-04-22 | Sell | 1.16K | $82K | 2026-04-22 | 2026-04-24 |
SEC filings
EDGAR filings in ARWR · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.